Comparison of creatinine-based equations for estimating renal function for digoxin dose adjustment in patients with atrial fibrillation and heart failure

被引:0
|
作者
Sakai, Masahiro [1 ]
Hirai, Toshinori [2 ,3 ]
Shitara, Satoshi [2 ]
Iwamoto, Takuya [3 ]
Shiga, Tsuyoshi [2 ,4 ,5 ]
机构
[1] Jikei Univ, Sch Med, Tokyo, Japan
[2] Jikei Univ, Dept Clin Pharmacol & Therapeut, Sch Med, Tokyo, Japan
[3] Mie Univ, Mie Univ Hosp, Fac Med, Dept Pharm, Tsu, Mie, Japan
[4] Tokyo Womens Med Univ, Dept Cardiol, Tokyo, Japan
[5] Jikei Univ, Dept Clin Pharmacol & Therapeut, Sch Med, 3-25-8 Nishi Shinbashi,Minato Ku, Tokyo 1058461, Japan
来源
PHARMACOLOGY RESEARCH & PERSPECTIVES | 2023年 / 11卷 / 01期
关键词
atrial fibrillation; digoxin; equation; glomerular filtration rate; heart failure; therapeutic drug monitoring; GLOMERULAR-FILTRATION-RATE; CLEARANCE; PREDICTION; DOSAGE;
D O I
10.1002/prp2.1050
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The aim of this study was to determine an appropriate equation for estimating renal function to dose regulate the serum digoxin trough concentration to a target of <0.9 ng/ml in patients with atrial fibrillation (AF) and heart failure (HF). All patients received 0.125 mg oral digoxin daily. The estimated glomerular filtration rate by the Modification of Diet in Renal Disease (eGFR(MDRD)) equation deindexed based on body surface area had the highest correlation with digoxin trough concentrations (r = -0.450) compared to the Cockcroft-Gault equation (r = -0.415) or deindexed eGFR based on the Chronic Kidney Disease Epidemiology Collaboration (eGFR(CKD-EPI)) equation (r = -0.416). The median digoxin trough concentrations were 0.60, 0.77, 0.97 and 1.30 ng/ml in patients with a deindexed eGFR(MDRD) >= 60, 45-59, 30-44 and < 30 ml/min, respectively. The deindexed eGFR(MDRD) is an appropriate equation for digoxin dose adjustment in patients with AF and HF.
引用
收藏
页数:6
相关论文
共 50 条
  • [41] Impact of digoxin use in patients with atrial fibrillation and heart failure: data from the Korean Heart Failure (KorHF) Registry
    Choi, S. -W.
    Han, S. W.
    Ahn, Y. K.
    Choi, D. J.
    Kim, J. J.
    Jeon, E. S.
    Cho, M. C.
    Chae, S. C.
    Lee, M. M.
    Ryu, K. H.
    EUROPEAN HEART JOURNAL, 2015, 36 : 666 - 666
  • [42] Impact of digoxin use in patients with atrial fibrillation and heart failure: data from the korean heart failure (KorHF) registry
    Choi, S-W Suk-Won
    Han, S. W.
    Ahn, Y.
    Choi, D. J.
    Kim, J. J.
    Jeon, E. S.
    Cho, M. C.
    Chae, S. C.
    Lee, M. M.
    Ryu, K. H.
    EUROPEAN JOURNAL OF HEART FAILURE, 2015, 17 : 39 - 39
  • [43] CHRONIC RENAL DISEASE AND ATRIAL FIBRILLATION IN PATIENTS WITH CHRONIC HEART FAILURE
    Shutov, A. M.
    Serov, V. A.
    Kurzina, E. V.
    Gerdt, A. M.
    Serova, D. V.
    TERAPEVTICHESKII ARKHIV, 2009, 81 (12) : 23 - 26
  • [44] Effect of atrial fibrillation on renal function in heart failure with reduced ejection fraction
    Ural, D.
    Argan, O.
    Karauzum, K.
    Bozyel, S.
    Aktas, M.
    Yilmaz, I.
    Dervis, E.
    Agir, A.
    EUROPEAN JOURNAL OF HEART FAILURE, 2015, 17 : 407 - 408
  • [45] The difference between cystatin C- and creatinine-based assessment of kidney function in acute heart failure
    Pinsino, Alberto
    Fabbri, Matteo
    Braghieri, Lorenzo
    Bohn, Bruno
    Gaudig, Antonia J.
    Kim, Andrea
    Takeda, Koji
    Naka, Yoshifumi
    Sayer, Gabriel T.
    Uriel, Nir
    Demmer, Ryan T.
    Faillace, Robert T.
    Husain, Syed A.
    Mohan, Sumit
    Colombo, Paolo C.
    Yuzefpolskaya, Melana
    ESC HEART FAILURE, 2022, 9 (05): : 3139 - 3148
  • [46] A deleterious interaction between omecamtiv mecarbil and atrial fibrillation in patients with heart failure: an influence of digoxin?
    van der Meer, Peter
    Rienstra, Michiel
    van Veldhuisen, Dirk J.
    EUROPEAN HEART JOURNAL, 2022, 43 (23) : 2221 - 2223
  • [47] Meta-Analysis of Effects of Digoxin on Survival in Patients with Atrial Fibrillation or Heart Failure: An Update
    Vamos, Mate
    Erath, Julia Wiebke
    Benz, Alexander Philipp
    Lopes, Renato Delascio
    Hohnloser, Stefan Hans
    AMERICAN JOURNAL OF CARDIOLOGY, 2019, 123 (01): : 69 - 74
  • [48] Use of digoxin is safe in patients with atrial fibrillation and heart failure: a nationwide propensity matched study
    Madelaire, C.
    Schou, M.
    Kristensen, K. E.
    Schmiegelow, M.
    Torp-Pedersen, C.
    Gustafsson, F.
    Kober, L.
    Gislason, G.
    EUROPEAN HEART JOURNAL, 2015, 36 : 716 - 716
  • [49] Utilization and safety of digoxin in patients with chronic heart failure and atrial fibrillation with rapid ventricular rate
    Berge, K.
    Schirmer, H.
    Kleiven, O.
    Grundtvig, M.
    Gullestad, L.
    Orn, S.
    Myhre, P. L.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [50] The association between atrial fibrillation and cognitive function in patients with heart failure
    Yang, Huifeng
    Niu, Weihua
    Zang, Xiaoying
    Lin, Mei
    Zhao, Yue
    EUROPEAN JOURNAL OF CARDIOVASCULAR NURSING, 2017, 16 (02) : 104 - 112